British health support service Synergy Health has acquired BeamOne in its first move into the US sterilisation market.
British health support service Synergy Health has acquired BeamOne in its first move into the US sterilisation market.
The deal is for an initial value of $35 million (£21.5million), but could rise by an additional $20 million depending on performance. The deferred payment period runs until 1 April 2012.
BeamOne is a US-based provider of medical device sterilisation, and will be used by Synergy to further its business activity in Asia, according to a statement released by the company.
Richard Steeves, chief executive of Synergy Health, comments: ‘This is a significant step for Synergy, providing us with an entry into one of the world’s largest and most established sterilisation markets.
‘BeamOne is a cultural and technological match to our own corporate philosophy. The new team will allow us to expand our technologies into the Americas and further enhance our technological capabilities in the electron beam sectors of our other international markets.’
The deal follows the purchase of German-based Gamma-Service Prodktbestrahlung in last December for $13.6 million.
Steeves reveals that the acquisitions are in line with Synergy’s strategy to expand its ‘geographic footprint’ into new markets.
BeamOne’s current executive and management groups will remain in place with former president and CEO of BeamOne, Glenn Thibault, becoming CEO of Synergy’s new America’s region.
Steeves adds: ‘The recent acquisitions reflect Synergy’s stated strategy to become a global leader in applied sterilisation services within the healthcare market for medical device manufacturers, hospitals and other healthcare providers.’
